MELISSA RUSTERUCCI: Open Payments
NPI 1467963892 · PEACHTREE CITY, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,476 in 78 payments from 18 companies in 2025. Trend: 2023 $1,083 · 2024 $1,183 · 2025 $1,476
Food & beverage: $1,476
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $255 |
| Lilly USA, LLC | 10 | $175 |
| ABBVIE INC. | 13 | $166 |
| Novo Nordisk Inc | 7 | $145 |
| Axsome Therapeutics, Inc. | 5 | $143 |
| PFIZER INC. | 6 | $105 |
| Corcept Therapeutics | 3 | $81 |
| Amgen Inc. | 4 | $64 |
| Noven Therapeutics, LLC | 3 | $61 |
| SANOFI-AVENTIS U.S. LLC | 3 | $43 |
Products named: AIRSUPRA, MOUNJARO, NURTEC ODT, Symbravo, VRAYLAR, Korlym, FARXIGA, Ozempic.
Industry payments across GA — which companies pay providers there.
